Compare PRAX & STRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | STRL |
|---|---|---|
| Founded | 2015 | 1955 |
| Country | United States | United States |
| Employees | N/A | 1740 |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 9.4B |
| IPO Year | 2020 | 1996 |
| Metric | PRAX | STRL |
|---|---|---|
| Price | $325.47 | $420.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 3 |
| Target Price | ★ $572.13 | $443.33 |
| AVG Volume (30 Days) | 364.5K | ★ 531.7K |
| Earning Date | 05-12-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 13.42 |
| EPS | N/A | ★ 9.38 |
| Revenue | N/A | ★ $957,958,000.00 |
| Revenue This Year | N/A | $20.76 |
| Revenue Next Year | $6,395.88 | $11.64 |
| P/E Ratio | ★ N/A | $44.36 |
| Revenue Growth | N/A | ★ 38.81 |
| 52 Week Low | $26.70 | $96.34 |
| 52 Week High | $354.87 | $477.03 |
| Indicator | PRAX | STRL |
|---|---|---|
| Relative Strength Index (RSI) | 53.52 | 54.32 |
| Support Level | $290.36 | $303.13 |
| Resistance Level | N/A | $470.00 |
| Average True Range (ATR) | 18.34 | 28.62 |
| MACD | -2.56 | -4.21 |
| Stochastic Oscillator | 57.24 | 31.95 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Sterling Infrastructure Inc is a construction company that specializes in heavy civil infrastructure construction and infrastructure rehabilitation as well as residential construction projects. The company operates in three reportable segments namely, Transportation Solutions, E-Infrastructure Solutions, and Building Solution. Transportation Solutions include highways, roads, bridges, airfields, ports, light rail, and others. Building Solution projects include concrete foundations for single-family homes. E-Infrastructure Solutions include the services which are provided to large, blue-chip companies in the e-commerce, data center, distribution center, and warehousing, energy, mixed-use, and multi-family sectors. The majority of the revenue is generated from E-Infrastructure Solutions.